老年肺癌围术期共病管理的研究进展:从风险评估到综合干预

doi:10.3969/j.issn.1003-9198.2026.06.016

摘要/Abstract

摘要： 老年肺癌的发病率和死亡率均较高,且常合并代谢性疾病、心血管疾病及慢性呼吸系统疾病等多种共病。复杂的共病状态不仅影响治疗方案的选择和手术耐受性,还显著增加围术期并发症及不良预后的发生风险,使围术期管理更为复杂。因此,老年肺癌围术期管理应以风险评估为核心,在老年综合评估基础上进一步整合共病、衰弱、认知、营养及功能状态等多维指标,探索多层次风险识别与分层管理策略。结合多学科团队协作下的精准干预,有助于为复杂共病状态下的老年肺癌患者提供个体化的围术期管理策略。未来需加强风险评估工具的标准化与临床应用,完善针对共病特征的整合管理模式,以提升老年肺癌患者围术期安全性及长期生活质量。

关键词: 共病, 老年肺癌, 围术期管理, 老年综合征

Abstract: Elderly patients show high incidence and mortality of lung cancer, often accompanied by comorbidities including metabolic, cardiovascular and chronic respiratory diseases. Such complex comorbidities affect treatment choices, surgical tolerance, and raise perioperative risks and poor prognosis, complicating clinical management.Perioperative care should focus on risk assessment based on comprehensive geriatric evaluation, integrating comorbidities, frailty, cognitive, nutritional and functional status to establish multi-level risk identification and stratified strategies. Multidisciplinary precise interventions help deliver personalized perioperative management.Future efforts should standardize risk assessment tools, strengthen clinical application and optimize comorbidity-oriented integrated models to improve perioperative safety and long-term quality of life for elderly lung cancer patients.

Key words: comorbidities, elderly lung cancer, perioperative management, geriatric syndromes

中图分类号:

R 734.2

叶莲, 梁瑞, 李霖龙, 葛宁. 老年肺癌围术期共病管理的研究进展:从风险评估到综合干预[J]. 实用老年医学, 2026, 40(6): 624-629.

YE Lian, LIANG Rui, LI Linlong, GE Ning. Research advances in perioperative comorbidity management for elderly lung cancer patients: from risk assessment to comprehensive intervention[J]. Practical Geriatrics, 2026, 40(6): 624-629.

参考文献

[1] FILDERMAN A E, SHAW C, MATTHAY R A. Lung cancer in the elderly [J]. Clin Geriatr Med, 1986, 2(2): 363-383.
[2] HEY J C. Lung cancer in elderly patients [J]. Clin Geriatr Med, 2003, 19(1): 139-155.
[3] BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
[4] JAKLITSCH M, BILLMEIER S. Preoperative evaluation and risk assessment for elderly thoracic surgery patients [J]. Thorac Surg Clin, 2009, 19(3): 301-312.
[5] O'ROURKE M A, CRAWFORD J. Lung cancer in the elderly [J]. Clin Geriatr Med, 1987, 3(4): 595-623.
[6] KORC-GRODZICKI B, DOWNEY R J, SHAHROKNI A, et al. Surgical considerations in older adults with cancer[J]. J Clin Oncol, 2014, 32(24): 2647-2653.
[7] ISLAM M M, VALDERAS J M, YEN L, et al. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns[J]. PLoS One, 2014, 9(1): e83783.
[8] PERRUCCIO A V, KATZ J N, LOSINA E. Health burden in chronic disease: multimorbidity is associated with self-rated health more than medical comorbidity alone [J]. J Clin Epidemiol, 2012, 65(1): 100-106.
[9] MARENGONI A, ANGLEMAN S, MELIS R, et al. Aging with multimorbidity: a systematic review of the literature[J]. Ageing Res Rev, 2011, 10(4): 430-439.
[10]TINETTI M E, FRIED T R, BOYD C M. Designing health care for the most common chronic condition: multimorbidity[J]. JAMA, 2012, 307(23): 2493-2494.
[11]DROZ J P, BALDUCCI L, BOLLA M, et al. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology[J]. BJU Int, 2010, 106(4): 462-469.
[12]CHARLSON M E, POMPEI P, ALES K L, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation[J]. J Chronic Dis, 1987, 40(5): 373-383.
[13]PHAM J, CONRON M, WRIGHT G, et al. Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?[J]. ERJ Open Res, 2021, 7(2). DOI:10.1183/23120541.00393-2020.
[14]LINN B S, LINN M W, GUREL L. Cumulative illness rating scale[J]. J Am Geriatr Soc, 1968, 16(5): 622-626.
[15]STUCK A E, SIU A L, WIELAND G D, et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials[J]. Lancet, 1993, 342(8878): 1032-1036.
[16]WONG M L, MCMURRY T L, SCHUMACHER J R, et al. Comorbidity assessment in the National Cancer Database for patients with surgically resected breast, colorectal, or lung cancer (AFT-01, -02, -03) [J]. J Oncol Pract, 2018, 14(10): e631-e643.
[17]JØRGENSEN T L, HALLAS J, FRIIS S, et al. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality[J]. Br J Cancer, 2012, 106(7): 1353-1360.
[18]MU X M, WANG W, WU F Y, et al. Comorbidity in older patients hospitalized with cancer in Northeast China based on hospital discharge data [J]. Int J Environ Res Public Health, 2020, 17(21): 8028.
[19]陈军, 车国卫, 孙大强, 等. 老年肺癌外科治疗中国专家共识(2022版)[J]. 中国肺癌杂志, 2023, 26(2): 83-92.
[20]ZHANG Z, FENG H, ZHAO H, et al. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study[J]. J Thorac Dis, 2019, 11(5): 1838-1848.
[21]MUGNAINI G, VIGGIANO D, FONTANARI P, et al. Awake uniportal VATS sublobar lung resections in high-comorbidity patients: single-center early post-operative outcomes [J]. Front Surg, 2023, 10:1120414.
[22]ZHU D, DING R, MA Y, et al. Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China[J]. BMC Cancer, 2021, 21(1): 557.
[23]HARUKI T, YURUGI Y, WAKAHARA M, et al. Simplified comorbidity score for elderly patients undergoing thoracoscopic surgery for lung cancer [J]. Surg Today, 2017, 47(6): 718-725.
[24]YANG C C, FONG Y, LIN L C, et al. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices[J]. Eur J Cardiothorac Surg, 2018, 53(1): 235-240.
[25]STEFFENS D, BECKENKAMP P R, HANCOCK M, et al. Preoperative exercise halves the postoperative complication rate in patients with lung cancer: a systematic review of the effect of exercise on complications, length of stay and quality of life in patients with cancer [J]. Br J Sports Med, 2018,52(5):344.
[26]LAI Y, HUANG J, YANG M, et al. Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial[J]. J Surg Res, 2017, 209: 30-36.
[27]BROCKI B C, ANDREASEN J J, LANGER D, et al. Postoperative inspiratory muscle training in addition to breathing exercises and early mobilization improves oxygenation in high-risk patients after lung cancer surgery: a randomized controlled trial [J]. Eur J Cardiothorac Surg, 2016,49(5):1483-1491.
[28]MICHAEL C M, LEHRER E J, SCHMITZ K H, et al. Prehabilitation exercise therapy for cancer: a systematic review and meta-analysis[J]. Cancer Med, 2021, 10(13): 4195-4205.
[29]ASSOULINE B, COOLS E, SCHORER R, et al. Preoperative exercise training to prevent postoperative pulmonary complications in adults undergoing major surgery. A systematic review and meta-analysis with trial sequential analysis[J]. Ann Am Thorac Soc, 2021, 18(4): 678-688.
[30]CAVALHERI V, JENKINS S, CECINS N, et al. Exercise training for people following curative intent treatment for non-small cell lung cancer: a randomized controlled trial [J]. Braz J Phys Ther, 2017,21(1):58-68.
[31]LI C, MENG H, WEI Y, et al. Postoperative outcomes of preoperative exercise training in patients with operable non-small cell lung cancer: a systematic review and meta-analysis[J]. Front Oncol, 2025, 15: 1563478.
[32]JEON H, WANG S, SONG J, et al. Update 2025: management of non-small-cell lung cancer [J]. Lung, 2025,203(1):53.
[33]IWATA E, HASEGAWA T, YAMADA S I, et al. Effects of perioperative oral care on prevention of postoperative pneumonia after lung resection: multicenter retrospective study with propensity score matching analysis[J]. Surgery, 2019, 165(5): 1003-1007.
[34]CYKERT S, ENG E, MANNING M A, et al. A multi-faceted intervention aimed at black-white disparities in the treatment of early stage cancers: the ACCURE Pragmatic Quality Improvement trial [J]. J Natl Med Assoc, 2020,112(5):468-477.
[35]THILLAINADESAN J, HILMER S N, FLEURY A M, et al. New horizons in the perioperative care of older adults[J]. Age Ageing, 2022, 51(2): afab245.
[36]WINGFIELD S A. The role of geriatric assessment in the care of older adults undergoing urologic cancer surgery [J]. Curr Opin Urol, 2024, 34(6): 438-443.
[37]PRABHAKAR C N, FONG K M, PEAKE M D, et al. The effectiveness of lung cancer MDT and the role of respiratory physicians[J]. Respirology, 2015, 20(6): 884-888.
[38]HARDAVELLA G, FRILLE A, THEOCHARI C, et al. Multidisciplinary care models for patients with lung cancer [J]. Breathe: Sheff, 2020, 16(4):200076.
[39]KOWALCZYK A, JASSEM J. Multidisciplinary team care in advanced lung cancer [J]. Transl Lung Cancer Res, 2020, 9(4):1690-1698.
[40]ELLIS G, GARDNER M, TSIACHRISTAS A, et al. Comprehensive geriatric assessment for older adults admitted to hospital [J]. Cochrane Database Syst Rev, 2017,9(9): CD006211.
[41]PARTRIDGE J S L, MOONESINGHE S R, LEES N, et al. Perioperative care for older people[J]. Age Ageing, 2022, 51(8): afac194.
[42]TAN S F, CHER B, BERIAN J R. Improving surgical outcomes for older adults with adoption of technological advances in comprehensive geriatric assessment[J]. Semin Colon Rectal Surg, 2024, 35(4). DOI:10.1016/j.scrs.2024.101060.
[43]EAMER G, TAHERI A, CHEN S S, et al. Comprehensive geriatric assessment for older people admitted to a surgical service[J]. Cochrane Database Syst Rev, 2018, 1(1): CD012485.